VR STOMOXIN INSECTICIDAL SPRAY CONCENTRATE FOR DOGS, HORSES AND CATTLE

Main information

  • Trade name:
  • VR STOMOXIN INSECTICIDAL SPRAY CONCENTRATE FOR DOGS, HORSES AND CATTLE
  • Class:
  • Veterinary Pesticide
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • VR STOMOXIN INSECTICIDAL SPRAY CONCENTRATE FOR DOGS, HORSES AND CATTLE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | DOG | HORSE | BEEF | BITCH | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | CASTRATE | COLT | CO
  • Therapeutic area:
  • INSECTICIDAL DIP/SPRAY
  • Therapeutic indications:
  • BITING INSECT | CANINE SUMMER ECZEMA | CAT FLEA | DOG FLEA | FLY | QUEENSLAND ITCH | FLEA ALLERGY DERMATITIS | HYPERSENSITIVITY TO CULICOIDES | SUMMER ECZEMA

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 36357
  • Last update:
  • 09-08-2016

5-12-2018

Public health risks associated with food‐borne parasites

Public health risks associated with food‐borne parasites

Published on: Tue, 04 Dec 2018 Parasites are important food‐borne pathogens. Their complex lifecycles, varied transmission routes, and prolonged periods between infection and symptoms mean that the public health burden and relative importance of different transmission routes are often difficult to assess. Furthermore, there are challenges in detection and diagnostics, and variations in reporting. A Europe‐focused ranking exercise, using multicriteria decision analysis, identified potentially food‐borne ...

Europe - EFSA - European Food Safety Authority Publications

26-11-2018

FDA Welcomes Grant Applications for Animal Drugs for Minor Uses and Minor Species

FDA Welcomes Grant Applications for Animal Drugs for Minor Uses and Minor Species

The U.S. Food and Drug Administration today announced an open period for applications for grants to support the development of new animal drugs intended to treat uncommon diseases (minor uses) in major species (horses, dogs, cats, cattle, pigs, turkeys and chickens) or to treat minor species.

FDA - U.S. Food and Drug Administration

24-9-2018

Ovitrelle (Merck Europe B.V.)

Ovitrelle (Merck Europe B.V.)

Ovitrelle (Active substance: Choriogonadotrophin alfa) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6220 of Mon, 24 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/320/T/75

Europe -DG Health and Food Safety

11-6-2018

Isentress (Merck Sharp and Dohme B.V.)

Isentress (Merck Sharp and Dohme B.V.)

Isentress (Active substance: raltegravir) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3767 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/860/T/75

Europe -DG Health and Food Safety